CorMedix (CRMD) Cash from Investing Activities (2016 - 2025)
CorMedix has reported Cash from Investing Activities over the past 12 years, most recently at $3.3 million for Q4 2025.
- Quarterly results put Cash from Investing Activities at $3.3 million for Q4 2025, up 1185.0% from a year ago — trailing twelve months through Dec 2025 was -$308.4 million (down 1552.73% YoY), and the annual figure for FY2025 was -$308.4 million, down 1552.73%.
- Cash from Investing Activities reached $3.3 million in Q4 2025 per CRMD's latest filing, up from -$291.3 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $8.9 million in Q1 2024 and bottomed at -$291.3 million in Q3 2025.
- Median Cash from Investing Activities over the past 5 years was -$256074.5 (2021), compared with a mean of -$15.9 million.
- The largest annual shift saw Cash from Investing Activities soared 32222.08% in 2023 before it crashed 4708.5% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$7.1 million in 2021, then soared by 99.97% to -$1861.0 in 2022, then skyrocketed by 32222.08% to $597792.0 in 2023, then tumbled by 150.83% to -$303874.0 in 2024, then skyrocketed by 1185.0% to $3.3 million in 2025.
- Business Quant data shows Cash from Investing Activities for CRMD at $3.3 million in Q4 2025, -$291.3 million in Q3 2025, and -$20.2 million in Q2 2025.